Literature DB >> 10554027

Effect of a cancer cachectic factor on protein synthesis/degradation in murine C2C12 myoblasts: modulation by eicosapentaenoic acid.

H J Smith1, M J Lorite, M J Tisdale.   

Abstract

The effect of a proteolysis inducing factor (PIF) on protein synthesis and degradation and the modulation of this effect by the polyunsaturated fatty acid, eicosapentaenoic acid (EPA), have been examined using a surrogate model system, C2C12 myoblasts in vitro. After 90 min of incubation, PIF produced a significant inhibition of protein synthesis in a dose-dependent manner, with maximal inhibition at a concentration of 4 nM. The effect was attenuated both by treatment with a monoclonal antibody to PIF and by treatment with insulin at physiological concentrations (1 nM) and below (0.1 nM), but not by EPA (50 microM). The inhibitory effect on protein synthesis was transitory and was not seen after prolonged incubation with PIF. An increased rate of protein degradation was observed in C2C12 myoblasts after addition of PIF, which was also maximal at a concentration of PIF of 4 nM. Higher concentrations of PIF did not produce an increase in protein degradation. Unlike the effect on protein synthesis, the enhanced protein degradation was completely abolished by pretreatment with 50 microM EPA, suggesting that the two effects are mediated by different mechanisms. PIF produced an increased release of [3H]arachidonic acid from prelabeled myoblasts with a dose-response curve parallel to that of protein degradation and with a maximum at 4 nM PIF. Release of [3H] arachidonic acid was completely blocked in cells pretreated with 50 microM EPA, suggesting that the effect was related to protein degradation. The [3H]arachidonic acid was rapidly metabolized to prostaglandins E2 and F2alpha and to 5-, 12-, and 15-hydroxyeicosatetraenoic acids (HETEs). Production of all eicosanoids was attenuated in cells pretreated with EPA. Of all of the metabolites, only 15-HETE produced a significant increase in protein degradation in C2C12 myoblasts with a maximal effect at 30 nM and with a bell-shaped dose-response curve similar to that produced by PIF. These results suggest that PIF enhances protein degradation as a result of an increased production of 15-HETE.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10554027

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  24 in total

1.  Lung injury-induced skeletal muscle wasting in aged mice is linked to alterations in long chain fatty acid metabolism.

Authors:  D Clark Files; Amro Ilaiwy; Traci L Parry; Kevin W Gibbs; Chun Liu; James R Bain; Osvaldo Delbono; Michael J Muehlbauer; Monte S Willis
Journal:  Metabolomics       Date:  2016-07-26       Impact factor: 4.290

Review 2.  Anorexia-Cachexia syndrome in cancer: implications of the ubiquitin-proteasome pathway.

Authors:  Carlos Camps; Vega Iranzo; Roy M Bremnes; Rafael Sirera
Journal:  Support Care Cancer       Date:  2006-07-04       Impact factor: 3.603

Review 3.  Molecular pathology of tumor metastasis III. Target array and combinatorial therapies.

Authors:  József Tímár; Andrea Ladányi; István Peták; András Jeney; László Kopper
Journal:  Pathol Oncol Res       Date:  2003-04-18       Impact factor: 3.201

4.  In vitro assessment of the combined effect of eicosapentaenoic acid, green tea extract and curcumin C3 on protein loss in C2C12 myotubes.

Authors:  Kamran A Mirza; Menghua Luo; Suzette Pereira; Anne Voss; Tapas Das; Michael J Tisdale
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-05-18       Impact factor: 2.416

5.  Mechanism of attenuation by beta-hydroxy-beta-methylbutyrate of muscle protein degradation induced by lipopolysaccharide.

Authors:  Steven T Russell; Michael J Tisdale
Journal:  Mol Cell Biochem       Date:  2009-04-30       Impact factor: 3.396

6.  Role of the dsRNA-dependent protein kinase (PKR) in the attenuation of protein loss from muscle by insulin and insulin-like growth factor-I (IGF-I).

Authors:  H L Eley; S T Russell; M J Tisdale
Journal:  Mol Cell Biochem       Date:  2008-03-23       Impact factor: 3.396

Review 7.  Fish oil supplementation in the treatment of cachexia in pancreatic cancer patients.

Authors:  Todd T Brown; Danielle L Zelnik; Adrian S Dobs
Journal:  Int J Gastrointest Cancer       Date:  2003

8.  Eicosapentaenoic acid enhances skeletal muscle hypertrophy without altering the protein anabolic signaling pathway.

Authors:  S Siriguleng; T Koike; Y Natsume; H Jiang; L Mu; Y Oshida
Journal:  Physiol Res       Date:  2021-01-14       Impact factor: 1.881

9.  Angiotensin II directly induces muscle protein catabolism through the ubiquitin-proteasome proteolytic pathway and may play a role in cancer cachexia.

Authors:  P M Sanders; S T Russell; M J Tisdale
Journal:  Br J Cancer       Date:  2005-08-22       Impact factor: 7.640

10.  Development of an in-vitro model system to investigate the mechanism of muscle protein catabolism induced by proteolysis-inducing factor.

Authors:  M C C Gomes-Marcondes; H J Smith; J C Cooper; M J Tisdale
Journal:  Br J Cancer       Date:  2002-05-20       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.